Tagged with Women's Health

Morocco Sofia Lahlou, country manager for women’s and children’s health specialist Versalya in the Moroccan market, discusses the company’s formation, its therapeutic priorities, and the opportunities that exist for women in leadership in Morocco.   Today, we are the only laboratory in Morocco exclusively dedicated to women’s and children’s well-being, supporting…

Morocco CEO Abdelhakim Tahri introduces women’s health player Gynebio Pharma, how the company is disrupting the Moroccan pharmaceutical industry through its range of contraceptive and fertility products, and his vision for regional expansion.   Our major focus when creating Gynebio Pharma was creating a company and a production facility that would…

Belgium Isabelle De Walsche, managing director of Gedeon Richter in Belgium, the Netherlands, and Luxembourg gives an update on the affiliate’s development since its establishment in 2012. De Waslche goes on to speak about the unique cluster dynamic which comes with managing the three markets and also highlights her priorities to…

France Speaking exclusively to PharmaBoardroom at the International Women’s Day 2020 event at the Franco-British Chamber of Commerce in Paris, esteemed cardiologist Professor Claire Mounier-Vehier outlines why cardiovascular disease is not simply a masculine issue, the cardio problems particularly affecting women, and why better communication and prevention is vital to countering…

Hungary Veronika Ferencz, general manager of Exeltis Hungary, gives an update on the recent activies and achievement of the affiliate since her last PharmaBoardroom interview in 2016. Furthermore, Ferencz goes on to highlight how the upcoming launch of the company’s first innovative product Slinda® is a very significant step in its…

Spain In what is a highly competitive and crowded women’s health field in Spain, smaller players are having to be increasingly focused and specialised to carve out a market share.   The [Spanish women’s health] market is very competitive since there are many companies and the sector is overwhelmingly a business…

Egypt Dr Sherif Rashed, managing partner and chairman of Magicpharma, explains how the company’s unique business model has allowed it to become one of the Top 50 pharmaceutical companies in Egypt in less than five years. He highlights Magicpharma’s ambitions in the areas of women’s health and supplements while improving the…

Opinion Kamala Maddali, vice president for Biopharma Collaborations & Companion Diagnostics at Cancer Genetics, discusses what impact next generation sequencing (NGS) stands to have on cancers that affect women.   NGS technology allows for the rapid and accurate sequencing of many genes at once 2018 saw an estimated 18 million cancer…

Korea YongBum Choi, general manager of Ferring Korea, explains how he plans to foster the Ferring values in the local affiliate. Mr Choi also breaks down the stigmas associated with assisted reproductive technologies and lays down Ferring’s ambitious growth strategy through breakthrough products launches every two years in Uro-Oncology & Gastroenterology.…

China Andras Gizur, president China & APAC for Gedeon Richter, shares his insights on the current market environment in China following the spate of recent healthcare reforms, the exciting innovations Gedeon Richter plans to launch in China in the next few years, the importance of fostering a friendly, cooperative and stable…

France Guillaume El Glaoui, co-founder and CEO of Laboratoires Majorelle, discusses what spurred the creation of the company, its success of gaining the first reimbursement ever of a condom in France, and the company’s core philosophy of social responsibility to public health.   We started with contraception and after a few…

Spain Inês Correia, general manager of the Iberia affiliate of HRA Pharma, a fast-growing consumer healthcare company and leader in women’s health, discusses her transition to the company and challenges in the Spanish environment in the context of emergency contraception (EC). Furthermore, Correia elaborates on HRA Pharma’s strong strategy in the…